| Mrs Heidi A Bollock, CNS | |
|
2559 Western Trails Blvd, Ste. 200, Austin, TX 78745-1554 | |
| (512) 899-2028 | |
| (512) 899-0311 |
| Full Name | Mrs Heidi A Bollock |
|---|---|
| Gender | Female |
| Speciality | Certified Clinical Nurse Specialist (cns) |
| Experience | 12 Years |
| Location | 2559 Western Trails Blvd, Austin, Texas |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1528311297 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 364SA2200X | Clinical Nurse Specialist - Adult Health | 775404 (Texas) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| St David's Medical Center | Austin, TX | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Davids Heart And Vascular Pllc | 7012821879 | 161 |
News Archive
A team from the UNIGE has developed an application that makes it possible to monitor the frequency and intensity of the symptoms of people at risk for psychosis on a daily basis, in order to be able to adapt their medical follow-up and determine the cause of the appearance of symptoms.
A synthetic, anti-inflammatory and anti-allergic family of drugs to combat a variety of illnesses while avoiding detrimental side effects has been developed by a Hebrew University of Jerusalem researcher.
A review of studies of possible linkages between type 2 diabetes and hearing impairment concludes there is compelling evidence that diabetes can damage the auditory system, and that clinicians should include hearing testing in managing type 2 diabetes. The survey results were published in an article titled, "Type 2 Diabetes and Hearing Impairment" in the journal, Current Diabetes Reports.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies, today announced that it was awarded two Small Business Innovation Research grants from the National Institutes of Health.
In the first Series paper, Self-harm and suicide in adolescents, Professor Keith Hawton, Dr Kate Saunders of the University of Oxford's Centre for Suicide Research, and Professor Rory O'Connor of University of Stirling's Suicidal Behaviour Research Laboratory, UK, examine existing research to look at the connections between self-harm and suicide in young people.
› Verified 4 days ago
| Entity Name | St Davids Heart & Vascular Pllc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1700887700 PECOS PAC ID: 7012821879 Enrollment ID: O20031117000103 |
News Archive
A team from the UNIGE has developed an application that makes it possible to monitor the frequency and intensity of the symptoms of people at risk for psychosis on a daily basis, in order to be able to adapt their medical follow-up and determine the cause of the appearance of symptoms.
A synthetic, anti-inflammatory and anti-allergic family of drugs to combat a variety of illnesses while avoiding detrimental side effects has been developed by a Hebrew University of Jerusalem researcher.
A review of studies of possible linkages between type 2 diabetes and hearing impairment concludes there is compelling evidence that diabetes can damage the auditory system, and that clinicians should include hearing testing in managing type 2 diabetes. The survey results were published in an article titled, "Type 2 Diabetes and Hearing Impairment" in the journal, Current Diabetes Reports.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies, today announced that it was awarded two Small Business Innovation Research grants from the National Institutes of Health.
In the first Series paper, Self-harm and suicide in adolescents, Professor Keith Hawton, Dr Kate Saunders of the University of Oxford's Centre for Suicide Research, and Professor Rory O'Connor of University of Stirling's Suicidal Behaviour Research Laboratory, UK, examine existing research to look at the connections between self-harm and suicide in young people.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Mrs Heidi A Bollock, CNS 7800 Shoal Creek Blvd, Ste. 205-n, Austin, TX 78757-1098 Ph: (512) 206-4300 | Mrs Heidi A Bollock, CNS 2559 Western Trails Blvd, Ste. 200, Austin, TX 78745-1554 Ph: (512) 899-2028 |
News Archive
A team from the UNIGE has developed an application that makes it possible to monitor the frequency and intensity of the symptoms of people at risk for psychosis on a daily basis, in order to be able to adapt their medical follow-up and determine the cause of the appearance of symptoms.
A synthetic, anti-inflammatory and anti-allergic family of drugs to combat a variety of illnesses while avoiding detrimental side effects has been developed by a Hebrew University of Jerusalem researcher.
A review of studies of possible linkages between type 2 diabetes and hearing impairment concludes there is compelling evidence that diabetes can damage the auditory system, and that clinicians should include hearing testing in managing type 2 diabetes. The survey results were published in an article titled, "Type 2 Diabetes and Hearing Impairment" in the journal, Current Diabetes Reports.
RXi Pharmaceuticals Corporation, a biotechnology company focused on discovering, developing and commercializing innovative therapies addressing major unmet medical needs using RNA-targeted and immunotherapy technologies, today announced that it was awarded two Small Business Innovation Research grants from the National Institutes of Health.
In the first Series paper, Self-harm and suicide in adolescents, Professor Keith Hawton, Dr Kate Saunders of the University of Oxford's Centre for Suicide Research, and Professor Rory O'Connor of University of Stirling's Suicidal Behaviour Research Laboratory, UK, examine existing research to look at the connections between self-harm and suicide in young people.
› Verified 4 days ago
Emily Allen Beddingfield, ACNS-BC Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 7000 N Mo Pac Expy. Ste. 420, Austin, TX 78731 Phone: 512-482-0045 Fax: 512-476-9892 | |
Susanne Morris, AGCNS Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 4101 James Casey St Ste 100, Austin, TX 78745 Phone: 512-447-2202 Fax: 512-447-5337 | |
Ryan Webb, Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 12731 Research Blvd Ste B200, Austin, TX 78759 Phone: 512-407-4088 | |
Mafon Fomujang, NURSE PRACTITIONER Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 2911 Medical Arts St Ste 10, Austin, TX 78705 Phone: 866-473-0663 | |
Carole L George, MSN, BC-ACNS, CDE Clinical Nurse Specialist Medicare: Not Enrolled in Medicare Practice Location: 6500 N Mo Pac Expy, Bldg. 3, Suite 200, Austin, TX 78731 Phone: 512-458-8400 Fax: 512-458-8593 | |
Mrs. Mary Ann Marcella Miranda, APRN, AHCNS-BC Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 3200 W Slaughter Ln, C/o West Oaks Rehabilitation And Healthcare Center, Austin, TX 78748 Phone: 512-992-7836 Fax: 512-364-0654 | |
Sarah Granger-glauser, RN, ACNS-BC Clinical Nurse Specialist Medicare: Accepting Medicare Assignments Practice Location: 711f W 38th St, Austin, TX 78705 Phone: 512-660-0195 Fax: 512-452-9171 |